Rifafour e-275 mg

DRUG2 trials

Sponsors

Global Alliance for TB Drug Development

Conditions

Pulmonary Tuberculosis

Phase 2

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (CL-010)

CompletedNCT00944021

Global Alliance for TB Drug DevelopmentPulmonary Tuberculosis

Start: 2009-08-31End: 2010-05-31Updated: 2019-09-20

Evaluation of Early Bactericidal Activity in Pulmonary Tuberculosis (TMC207-CL001)

CompletedNCT01215110

Global Alliance for TB Drug DevelopmentPulmonary Tuberculosis

Start: 2010-04-30End: 2010-09-30Updated: 2017-04-26